HomeDMAA • NASDAQ
add
Drugs Made In America Acquisition Corp
Previous close
$10.16
Day range
$10.15 - $10.17
Year range
$9.95 - $10.27
Market cap
340.53M USD
Avg Volume
127.24K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 330.92K | — |
Net income | 1.25M | — |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 923.00 | — |
Total assets | 232.81M | — |
Total liabilities | 239.98M | — |
Total equity | -7.18M | — |
Shares outstanding | 33.52M | — |
Price to book | -42.35 | — |
Return on assets | -0.71% | — |
Return on capital | 24.70% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 1.25M | — |
Cash from operations | -251.24K | — |
Cash from investing | -231.15M | — |
Cash from financing | 231.40M | — |
Net change in cash | -428.00 | — |
Free cash flow | -120.16K | — |
About
Founded
2024
Website
